Literature DB >> 28453757

Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011].

E Bequet1, H Sarter2,3, M Fumery4, F Vasseur5, L Armengol-Debeir6, B Pariente7, D Ley1,3, C Spyckerelle8, H Coevoet9, J E Laberenne10, L Peyrin-Biroulet11, G Savoye6, D Turck1,3, C Gower-Rousseau2,3.   

Abstract

BACKGROUND AND AIMS: Very-early-onset inflammatory bowel disease [VEO-IBD] is a form of IBD that is distinct from that of children with an older onset. We compared changes over time in the incidence and phenotype at diagnosis between two groups according to age at IBD diagnosis: VEO-IBD diagnosed before the age of 6 years, and early-onset IBD [EO-IBD] diagnosed between 6 and 16 years of age.
METHODS: Data were obtained from a cohort enrolled in a prospective French population-based registry from 1988 to 2011.
RESULTS: Among the 1412 paediatric cases [< 17 years], 42 [3%] were VEO-IBD. In the VEO-IBD group, the incidence remained stable over the study period. In contrast, the incidence of EO-IBD increased from 4.4/105 in 1988-1990 to 9.5/105 in 2009-2011 [+116%; p < 10-4]. Crohn's disease [CD] was the most common IBD, regardless of age, but ulcerative colitis [UC] and unclassified IBD were more common in VEO-IBD cases [40% vs 26%; p = 0.04]. VEO-IBD diagnosis was most often performed in hospital [69% vs 43%; p < 10-3]. Rectal bleeding and mucous stools were more common in patients with VEO-IBD, whereas weight loss and abdominal pain were more frequent in those with EO-IBD. Regarding CD, isolated colonic disease was more common in the VEO-IBD group [39% vs 14%; p = 0.003].
CONCLUSIONS: In this large population-based cohort, the incidence of VEO-IBD was low and stable from 1988 to 2011, with a specific clinical presentation. These results suggest a probable genetic origin for VEO-IBD, whereas the increase in EO-IBD might be linked to environmental factors.
Copyright © 2016 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  Inflammatory bowel disease; clinical presentation; incidence; paediatric; very-early-onset

Mesh:

Year:  2017        PMID: 28453757     DOI: 10.1093/ecco-jcc/jjw194

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  21 in total

1.  Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells.

Authors:  Haider Rasheed Alrafas; Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Leukoc Biol       Date:  2019-03-21       Impact factor: 4.962

2.  Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis.

Authors:  Suresh Venkateswaran; Jarod Prince; David J Cutler; Urko M Marigorta; David T Okou; Sampath Prahalad; David Mack; Brendan Boyle; Thomas Walters; Anne Griffiths; Cary G Sauer; Neal LeLeiko; David Keljo; James Markowitz; Susan S Baker; Joel Rosh; Marian Pfefferkorn; Melvin B Heyman; Ashish Patel; Anthony Otley; Robert Baldassano; Joshua Noe; Paul Rufo; Maria Oliva-Hemker; Sonia Davis; Michael E Zwick; Greg Gibson; Lee A Denson; Jeffrey Hyams; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2018-03-19       Impact factor: 5.325

Review 3.  Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations.

Authors:  Anne E Levine; Hengqi B Zheng; David L Suskind
Journal:  Paediatr Drugs       Date:  2022-04-25       Impact factor: 3.022

Review 4.  Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.

Authors:  Adi Eindor-Abarbanel; Genelle R Healey; Kevan Jacobson
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

5.  Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants.

Authors:  Yun-E Chen; Jingfang Chen; Wenxing Guo; Yanhong Zhang; Jialing Li; Hui Xie; Tong Shen; Yunsheng Ge; Yanru Huang; Wenying Zheng; Mei Lu
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

Review 6.  Very early-onset inflammatory bowel disease: an integrated approach.

Authors:  Kathleen E Sullivan; Maire Conrad; Judith R Kelsen
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-12

Review 7.  Very Early Onset-IBD: evidence for the need of a multidisciplinary approach.

Authors:  Paola Parente; Maria Pastore; Federica Grillo; Matteo Fassan; Paola Francalanci; Angelica Dirodi; Chiara Rossi; Giovanni Arpa; Paola De Angelis; Irene Gullo; Luca Mastracci; Rita Alaggio; Alessandro Vanoli
Journal:  Pathologica       Date:  2021-12-02

Review 8.  Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.

Authors:  Jodie Ouahed; Elizabeth Spencer; Daniel Kotlarz; Dror S Shouval; Matthew Kowalik; Kaiyue Peng; Michael Field; Leslie Grushkin-Lerner; Sung-Yun Pai; Athos Bousvaros; Judy Cho; Carmen Argmann; Eric Schadt; Dermot P B Mcgovern; Michal Mokry; Edward Nieuwenhuis; Hans Clevers; Fiona Powrie; Holm Uhlig; Christoph Klein; Aleixo Muise; Marla Dubinsky; Scott B Snapper
Journal:  Inflamm Bowel Dis       Date:  2020-05-12       Impact factor: 5.325

9.  Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease.

Authors:  Kwang Yeon Kim; Eun Joo Lee; Ju Whi Kim; Jin Soo Moon; Ju Young Jang; Hye Ran Yang; Jae Sung Ko
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-01-12

10.  Inflammatory bowel disease: Clinical screening and transition of care.

Authors:  Badr Al-Bawardy
Journal:  Saudi J Gastroenterol       Date:  2017 Jul-Aug       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.